Meredith sells Viant stake back to founders

The move by Viant to go independent is also swimming against the ad-tech curve, as demand-side platforms are getting picked up (AT&T's deal for AppNexus; Roku's deal for Dataxu).

Up Next

Viant Enhances Programmatic Pharmaceutical Offering With New Data Partnerships

Viant announces an enhanced offering for pharmaceutical marketers, providing accuracy and dependability when marketers execute both direct to consumer (DTC) and healthcare provider (HCP) campaigns.

Read More